Sirnaomics Ltd Sustainability Reports

Sirnaomics Ltd. is a clinical-stage biopharmaceutical company focused on the discovery and development of RNAi therapeutics. The company develops targeted therapies utilizing proprietary delivery platforms for indications in oncology, fibrosis, cardiometabolic disorders, and medical aesthetics.

Sector: Manufacturing

Country: Hong Kong

Exchange: Hong Kong Stock Exchange

LEI: 2549004JEEDTBC6EHW37

FIGI: BBG0146LBQM3

7 reports from 2021 to 2025

• Sirnaomics Ltd 2025 Environmental, Social and Governance Report
• Sirnaomics Ltd 2024 Annual Report
• Sirnaomics Ltd 2024 Environmental, Social and Governance Report
• Sirnaomics Ltd 2023 Annual Report
• Sirnaomics Ltd 2023 Environmental, Social and Governance Report